Universal Health Realty Income Trust UHT

FY2025 · ended Dec 31, 2025 · Revenue $99.19M, +0.2% YoY · Filed Feb 25, 2026

Universal Health Realty Income Trust (UHT) files with the SEC under industry code 6798, Real Estate Investment Trusts. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $99.2 million and net income of $17.6 million. As of Jun 30, 2026 it held $6.8 million in cash and investments and $11.4 million in total debt.

Revenue (TTM)
$99.29M
+0.8% vs year-ago TTM
Net income (TTM)
$19.27M
+7.5% vs year-ago TTM
Operating cash flow (TTM)
$48.15M
-0.4% vs year-ago TTM
Free cash flow
$35.32M
+6.4% vs prior year
EPS (TTM)
$1.39
+7.3% vs year-ago TTM
Dividend per share (TTM)
$2.98
+1.4% vs year-ago TTM
Shares outstanding
13.87M
+0.2% vs prior year
Net cash
$-4.58M
as of Jun 30, 2026
Operating margin
35.3%
FY 2026

Company profile

Industry
Real Estate Investment Trusts (SIC 6798)
Listed as
UHT (NYSE)
Fiscal year ends
December 31
Incorporated in
MD
Headquarters
King Of Prussia, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
798783

Other Real Estate Investment Trusts companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$99.2M
$99.0M
$95.6M
$90.6M
$84.2M
Operating income
$34.8M
$36.8M
$31.3M
$30.7M
$28.9M
Net income
$17.6M
$19.2M
$15.4M
$21.1M
$109.2M
Diluted EPS
$1.27
$1.39
$1.11
$1.53
$7.92
Operating cash flow
$49.1M
$46.9M
$42.9M
$46.8M
$47.7M
Free cash flow
—
—
$35.3M
$33.2M
$34.7M
Total assets
$564.9M
$580.9M
$596.4M
$607.5M
$598.4M
Total liabilities
$412.5M
$401.3M
$395.4M
$378.4M
$363.1M
Stockholders' equity
$152.4M
$179.5M
$200.9M
$229.1M
$235.3M
Cash and investments
$6.7M
$7.1M
$8.2M
$7.6M
$22.5M
Total debt
$386.2M
$379.3M
$370.6M
$354.5M
$340.5M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Oct 27, 2026 Oct 27, 2026
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 27, 2026 Jul 27, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 11, 2026 Jun 10, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.